CoChat

Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1‐42

Schott, Jonathan M., Bartlett, Jonathan W., Fox, Nick C., Barnes, Josephine, for the Alzheimer's Disease Neuroimaging Initiative Investigators · 2010 · Annals of Neurology
Cited by 151

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Objective: To identify cognitively normal individuals at risk of Alzheimer disease (AD) based on cerebrospinal fluid (CSF) Aβ1‐42, and to determine rates of cerebral atrophy. Methods: Control subjects from the Alzheimer's Disease Neuroimaging Initiative with CSF and serial magnetic resonance imaging (MRI) were dichotomized on CSF Aβ1‐42 (normal control [NC]‐high >192pg/ml; NC‐low ≤192pg/ml). Baseline and 1‐year MRIs were registered, and brain, hippocampal, and ventricular volumes and annualized volume changes were calculated. Baseline characteristics, CSF profiles, neuropsychology, brain volumes and atrophy rates, and APOE, PICALM, CLU, and TOMM40 genotypes were compared. Sample sizes to power presymptomatic clinical trials based on rate of atrophy were calculated. Results: Forty of 105 (38%) were classified as NC‐low, and 65 (62%) as NC‐high. There were no differences in age (76.3 ± 5.1 vs 74.9 ± 5.1 years), gender, brain volumes, and all but 1 cognitive score (Trails B; p = 0.015). The NC‐low group had higher tau (p = 0.005) and p‐tau (p < 0.001), and was more likely to be APOE4 positive (48% vs 11%, p < 0.001). The NC‐low group had significantly higher whole brain loss (9.3 vs 4.4ml/yr, p < 0.001), ventricular expansion (2.04 vs 0.95ml/yr, p = 0.002), and hippocampal atrophy rate (0.07 vs 0.03ml/yr, p = 0.029). Baseline Aβ1‐42 level was strongly correlated with rate of brain atrophy only in the NC‐low group (p < 0.001). Using 141 (95% confidence interval, 86–287) patients per arm provides 80% power in a 1‐year treatment trial to show 25% slowing of brain atrophy in the NC‐low group. Interpretation: A significant percentage of healthy older adults have CSF profiles consistent with AD and increased rates of brain atrophy, suggesting that they may be in the earliest stages of neurodegeneration. Brain atrophy may be a feasible outcome measure for AD prevention studies. Ann Neurol 2010.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.22315

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 151

Metadata

Authors
Schott, J. M., Bartlett, J. W., Fox, N. C., Barnes, J., & for the Alzheimer's Disease Neuroimaging Initiative Investigators
Venue
Annals of Neurology
Publisher
Wiley
Published
2010-12
Volume
68
Issue
6
Pages
825-834
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1978684823
Cited by
151
References
20
FWCI
10.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1‐42. https://app.cochat.ai/papers/10.1002/ana.22315
The paper
Schott, J. M., Bartlett, J. W., Fox, N. C., Barnes, J., & for the Alzheimer's Disease Neuroimaging Initiative Investigators. (2010). Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1‐42. Annals of Neurology. https://doi.org/10.1002/ana.22315

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.